Cancer

Repeated price cuts take glow off Endocyte IPORestricted Content

February 12, 2011
Greg Andrews
New investors got in for $6 a share—which is less than the average price paid by prior investors, a regulatory filing reveals.
More

Head of Lilly's oncology unit resigning

January 25, 2011
John H. Johnson has been hired as CEO by East Brunswick, N.J.-based biotechnology company Savient Pharmaceuticals Inc.
More

Lilly suspends late-stage trial for melanoma drug

December 13, 2010
Bloomberg News
Eli Lilly and Co. suspended a late-stage clinical trial of a medicine for skin-cancer patients after 12 patients in the study died.
More

Group says billboard companies rejected anti-Lilly ad

November 3, 2010
Scott Olson
San Francisco-based Breast Cancer Action wanted its message, "Eli Lilly is making us sick. Tell them to stop," posted on local billboards. But numerous sign companies refused, the group said.
More

Cancer researcher battling Semafore in courtRestricted Content

May 29, 2010
Chris O'Malley
Former collaborator alleges firm breached its agreement with him and refused to pay royalty income.
More

Positron has billion-dollar hopes for medical-imaging scanner

May 29, 2010
J.K. Wall
A maker of medical imaging equipment that recently moved its headquarters to Fishers has grand plans to reach $1 billion in sales and build a multimillion-dollar cyclotron facility in five years. But history shows Positron Corp. has been far better at losing money than making it.
More

WellPoint pledges two-day hospital stays after mastectomy

May 26, 2010
J.K. Wall
In the company's latest response to withering criticism of its breast-cancer policies, WellPoint Inc. said it will pay for any breast cancer patient to stay two days in a hospital after surgery.
More

Purdue secures $15M to expand cancer research building

April 12, 2010
J.K. Wall
Stimulus dollars from the National Institutes of Health expected to spark 30 to 40 new research jobs by 2013.
More

DAVIS: Finding (and keeping) clarity through cancer

March 27, 2010
Andrea Muirragui Davis
Almost eight months ago, I used this space to share the new perspective on life I discovered as a side effect of my battle with cancer. A lot has happened since then, and I’m still marveling at the difference—even as I struggle to hold onto it.
More

Health care bill burns local tanning industry

March 26, 2010
Anthony Schoettle
With one of the nation's largest tanning-bed manufacturers and dozens of salons in central Indiana, a 10-percent tax on tanning could cost the region jobs.
More

IU cancer center names new director

March 2, 2010
 IBJ Staff
Dr. Patrick J. Loehrer Sr. replaces Dr. Stephen D. Williams, the center's founding director, who died of cancer in February 2009.
More

House approves smoking ban in public places

February 23, 2010
Associated Press
The House has approved legislation that would ban smoking in public places statewide except casinos and pari-mutuel horse racing venues.
More

Enzon Pharmaceuticals sells Indy drug plant; 100 local jobs safe

February 1, 2010
New Jersey-based Enzon Pharmaceuticals Inc. has sold its Indianapolis plant that manufactures specialty drugs in a deal that could top $300 million. The buyer says that the operations, which employ about 100, will remain in the city.
More

HICKS: New breast cancer recommendation not supportedRestricted Content

November 28, 2009
Mike Hicks
Under the current proposal, the same type of groups that made the CDC's recommendations will outline guidelines about which treatment will be offered under a government program.
More

Indy Chamber of Commerce endorses smoking ban

October 26, 2009
Cory Schouten
The Indianapolis Chamber of Commerce is throwing its weight behind a tougher workplace smoking ban up for consideration tonight by the City-County Council.
More

Lilly, GE announce cancer diagnostic breakthrough

October 21, 2009
J.K. Wall
Eli Lilly and Co. and General Electric Co. say they've made a breakthrough in cancer research that could help Lilly cut the size and cost of its clinical trials.
More

Endocyte receives $26M infusion from investors

October 16, 2009
West Lafayette-based Endocyte Inc. announced Friday that it has closed on $26 million in equity financing to help the company continue developing cancer-fighting drugs.
More

DAVIS: Looming deadline not so big now

August 17, 2009
Andrea Muirragui Davis
The exact words the doctor used that day are forever lost in a blur of hospital gowns and ultrasound gel and post-biopsy instructions.
More

Endocyte, Purdue develop prostate cancer treatment device

July 13, 2009
 IBJ Staff
Purdue University researcher Philip Low, also the chief science officer for West Lafayette-based Endocyte Inc., has developed a prostate cancer “homing device” to help anti-cancer agents specifically target prostate cancer tumors.

More

Cook splits device unit to focus on cancer productsRestricted Content

February 9, 2009
Cook Medical has split its interventional devices business into two units, pulling its lesser known cancer products out from under the shadow of its heart products.
More

Lilly buys ImClone as part of strategy to capitalize on cancer-drug marketRestricted Content

October 13, 2008
J.K. Wall

Eli Lilly and Co. has written a $6.5 billion IOU to acquire the cancer drugs of ImClone Systems Inc. Cancer drugs are now the best-selling class of drugs in the world and one of the fastest growing.


More
Page  << 1 2 pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT